¼¼°èÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå
Endoscope Reprocessing
»óǰÄÚµå : 1766978
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 288 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

³»½Ã°æ Àçó¸® ¼¼°è ½ÃÀåÀº 2030³â±îÁö 50¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 32¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ³»½Ã°æ Àçó¸® ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 7.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 50¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °í·¹º§ ¼Òµ¶Á¦ ¹× Å×½ºÆ® ½ºÆ®¸³Àº CAGR 8.4%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 14¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¼Á¦ ¹× ¹°Æ¼½´ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 6.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 8¾ï 2,690¸¸ ´Þ·¯, Áß±¹Àº CAGR 11.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³»½Ã°æ Àçó¸® ½ÃÀåÀº 2024³â¿¡ 8¾ï 2,690¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 12¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 4.0%¿Í 7.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³»½Ã°æ Àçó¸® ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³»½Ã°æ Àç󸮰¡ ÇコÄɾ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

³»½Ã°æ Àç󸮴 Áø´Ü ¹× ¼ö¼ú¿¡ »ç¿ëµÇ´Â ³»½Ã°æ Àåºñ°¡ ȯÀÚ¸¶´Ù öÀúÇÏ°Ô ¼¼Ã´, ¼Òµ¶ ¹× ¸ê±ÕµÇµµ·Ï ¼³°èµÈ ÀÇ·á ȯ°æ¿¡¼­ Áß¿äÇÑ ÀýÂ÷ÀÔ´Ï´Ù. ÀûÀýÇÑ Àç󸮴 ƯÈ÷ Àç»ç¿ëÀÌ °¡´ÉÇϰí Á¡¸·À̳ª ¹«±Õ Á¶Á÷°ú Á¢ÃËÇÏ´Â °æ¿ì°¡ ¸¹Àº ³»½Ã°æÀÇ ÀÌÂ÷ ¿À¿° ¹× °¨¿° ÀüÆÄ¸¦ ¹æÁöÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ³»½Ã°æ Àç󸮿¡´Â Àü¼¼Ã´, °í¼öÁØ ¼Òµ¶, Çó±À, °ÇÁ¶, º¸°ü µî ¿©·¯ ´Ü°è°¡ Æ÷ÇԵǸç, °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ º¸°Ç ´ç±¹¿¡ ÀÇÇØ ¾ö°ÝÇÏ°Ô ±ÔÁ¦µÇ°í ÀÖ½À´Ï´Ù.

³»½Ã°æ Àçó¸® °øÁ¤¿¡ ´ëÇÑ ¼ö¿ä´Â ¼ÒÈ­±â, ºñ´¢±â°ú, È£Èí±â µî ³»½Ã°æÀÌ ÃÖ¼Òħ½ÀÀû ½Ã¼ú¿¡ ÀÚÁÖ »ç¿ëµÇ´Â ºÐ¾ß¿¡¼­ ƯÈ÷ ³ô½À´Ï´Ù. ÀÇ·á °ü·Ã °¨¿°(HAI)ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ½Ã¼³¿¡¼­´Â ȯÀÚÀÇ ¾ÈÀü°ú ±ÔÁ¤ Áؼö¸¦ À§ÇØ ¾ö°ÝÇÑ Àçó¸® ÇÁ·ÎÅäÄÝÀ» Áß¿ä½ÃÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ Àçó¸® Àåºñ, °í¼öÁØ ¼Òµ¶Á¦, °ÇÁ¶ ¹× º¸°ü ½Ã½ºÅÛ°ú °°Àº ³»½Ã°æ Àçó¸® ¼Ö·ç¼ÇÀº º´¿ø, Áø·á¼Ò, ¿Ü·¡ ȯÀÚ ¼¾ÅÍ¿¡¼­ ÇʼöÀûÀ̸ç, Àü ¼¼°è ÀÇ·á ½Ã¼³¿¡¼­ ³ôÀº ¼öÁØÀÇ À§»ý °ü¸®¿Í ȯÀÚ Ä¡·á¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ³»½Ã°æ Àçó¸® ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº È¿À²¼º, ÀÚµ¿È­ ¹× ¾ÈÀü Ç¥ÁØ Áؼö¸¦ Çâ»ó½ÃÅ´À¸·Î½á ³»½Ã°æ Àçó¸® °øÁ¤À» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÚµ¿ ³»½Ã°æ Àç󸮱â(AER)´Â °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª·Î, ³»½Ã°æ ¼¼Ã´ ¹× ¼Òµ¶À» À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ°í ÀϰüµÇ°í Ç¥ÁØÈ­µÈ ÇÁ·Î¼¼½º¸¦ Á¦°øÇÏ¿© Àçó¸® ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí, ¼öÀÛ¾÷À» ÁÙÀ̸ç, ÀÎÀû ¿À·ùÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí, °¢ ³»½Ã°æÀÌ ¾ö°ÝÇÑ °¡À̵å¶óÀο¡ µû¶ó ó¸®µÉ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. °¡À̵å¶óÀο¡ µû¶ó °¢ ³»½Ã°æÀÌ Ã³¸®µÇµµ·Ï º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, AERÀº Á¾Á¾ µðÁöÅÐ ÃßÀû ¹× ¹®¼­È­ ±â´ÉÀ» °®Ãß°í ÀÖ¾î ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ǰÁú °ü¸® ¹× ±ÔÁ¤ Áؼö¸¦ À§ÇØ Á¤È®ÇÑ ±â·ÏÀ» À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.

º¸´Ù ºü¸£°í È¿°úÀûÀÎ º´¿øÃ¼ Á¦°Å¸¦ ½ÇÇöÇϰí ÀÇ·áÁø°ú ȯ°æ¿¡ ¾ÈÀüÇÑ Á¦Á¦¸¦ Á¦°øÇÏ´Â º¸´Ù Áøº¸µÈ ¼Òµ¶Á¦ ¹× ¸ê±ÕÁ¦µµ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ´õ ªÀº »çÀÌŬ ŸÀÓ°ú ±¤¹üÀ§ÇÑ Ç×±Õ È¿°ú¸¦ °¡Áø »õ·Î¿î °í¼öÁØ ¼Òµ¶Á¦´Â ³»½Ã°æÀÇ Ã³¸® ½Ã°£À» °³¼±ÇÏ°í ´õ ºü¸¥ ȯÀÚ Ä¡·á¸¦ Áö¿øÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÚµ¿ °ÇÁ¶ ijºñ´Ö ¹× ÇÊÅ͸µµÈ °ø±â ½Ã½ºÅÛ°ú °°Àº °ÇÁ¶ ¹× º¸°ü ¼Ö·ç¼ÇÀÇ ¹ßÀüÀ¸·Î ³»½Ã°æÀÌ ÀûÀýÈ÷ °ÇÁ¶µÇ°í ¿À¿°µÇÁö ¾ÊÀº ȯ°æ¿¡¼­ º¸°üµÇ¾î °¨¿° À§ÇèÀ» ´õ¿í ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î ³»½Ã°æ Àç°¡°øÀº ´õ ºü¸£°í, ´õ ¾ÈÀüÇϸç, ´õ ¾ö°ÝÇÑ ÀÇ·á Ç¥ÁØÀ» ÁؼöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

³»½Ã°æ Àçó¸®ÀÇ ÁÖ¿ä ¿ëµµ´Â?

³»½Ã°æ Àç󸮴 ¼ÒÈ­±â³»°ú, È£Èí±â³»°ú, ºñ´¢±â°ú, ÀϹݿܰú µî ³»½Ã°æ ½Ã¼úÀÌ ÀÌ·ç¾îÁö´Â ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¼ÒÈ­±â³»°ú¿¡¼­´Â ´ëÀå³»½Ã°æ °Ë»ç, À§³»½Ã°æ °Ë»ç, ERCP(³»½Ã°æÀû ¿ªÇ༺ ´ã°ü Ãé´ã°ü Á¶¿µ¼ú) µî¿¡ »ç¿ëµÇ´Â ¿¬¼º ³»½Ã°æÀº ü³» Á¶Á÷°úÀÇ Á¢ÃËÀ¸·Î ¸ê±ÕµÈ ±â±¸°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ Àç󸮸¦ ÅëÇØ ¾ÈÀüÇÏ°Ô Àç»ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î È£Èí±â³»°ú¿¡¼­ ±âµµ °Ë»ç³ª Æó »ý°Ë¿¡ »ç¿ëµÇ´Â ±â°üÁö°æÀº ȯÀÚÀÇ È£Èí±â °¨¿°À» ¿¹¹æÇϱâ À§ÇØ Àç󸮵˴ϴÙ.

ºñ´¢±â°ú¿¡¼­ ¿ä·ÎÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ »ç¿ëµÇ´Â ¹æ±¤°æÀº ¿ä·Î°¨¿°ÁõÀÇ °¨¿°À» ¿¹¹æÇϱâ À§ÇØ ¾ö°ÝÇÑ Àç󸮸¦ °ÅĨ´Ï´Ù. ¶ÇÇÑ, ¿Ü°ú¿¡¼­´Â ÃÖ¼Òħ½À ¼ö¼ú ½Ã ¹«±Õ »óŸ¦ À¯ÁöÇϱâ À§ÇØ º¹°­°æ, °üÀý°æ µîÀÇ °æ¼º ³»½Ã°æÀ» Àçó¸®Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àçó¸® ÀýÂ÷´Â ¸ðµç ³»½Ã°æ Àåºñ°¡ ¿À¿°µÇÁö ¾Êµµ·Ï º¸ÀåÇϰí, ȯÀÚÀÇ ¾ÈÀüÀ» Áö¿øÇϸç, ÀÇ·á ½Ã¼³ Àüü¿¡¼­ ³ôÀº ¼öÁØÀÇ °¨¿° °ü¸®¸¦ À¯ÁöÇÕ´Ï´Ù. °¢ ¾ÖÇø®ÄÉÀ̼ÇÀº °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ°í ¾ÈÀüÇϰí È¿°úÀûÀΠȯÀÚ Ä¡·á¸¦ º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ Àçó¸® ÇÁ·ÎÅäÄÝÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

³»½Ã°æ Àçó¸® ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀº ¹«¾ùÀΰ¡?

³»½Ã°æ Àçó¸® ½ÃÀåÀÇ ¼ºÀåÀº ³»½Ã°æ ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °¨¿° ¿¹¹æ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ³ôÀº ¼öÁØÀÇ ¼Òµ¶¿¡ ´ëÇÑ ±ÔÁ¦ ¾Ð·Â, Àçó¸® ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÃÖ¼Òħ½ÀÀû ³»½Ã°æ ½Ã¼úÀÌ Áø´Ü ¹× Ä¡·á ºÐ¾ß¿¡¼­ º¸ÆíÈ­µÊ¿¡ µû¶ó È¿°úÀûÀÎ Àçó¸® ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ ³ôÀº ȯÀÚ Ã³¸®·®À» ó¸®ÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ Àçó¸® ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á °ü·Ã °¨¿°(HAI)¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ȯÀÚ ¾ÈÀü°ú ÀÇ·á ºñ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ½Ã¼³Àº ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼Òµ¶°ú ÃßÀû¼ºÀ» Á¦°øÇϴ ÷´Ü Àçó¸® ½Ã½ºÅÛÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù.

FDA, CDC ¹× Àü ¼¼°è ¿©·¯ º¸°ÇºÎ¿Í °°Àº ±ÔÁ¦ ±â°üÀº ³»½Ã°æÀÇ ¾ö°ÝÇÑ Àçó¸® ±âÁØÀ» °­Á¦Çϰí, ±ÔÁ¤ Áؼö¿Í Ã¥ÀÓÀ» º¸ÀåÇϱâ À§ÇØ Æ¯Á¤ ÇÁ·ÎÅäÄݰú ¹®¼­È­¸¦ Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. °¨¿° ¿¹¹æ¿¡ ´ëÇÑ ÀÌ·¯ÇÑ ±ÔÁ¦ ÃÊÁ¡Àº ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·Çϰí HAI ¹ß»ý °¡´É¼ºÀ» ÁÙÀÌ´Â ÀÚµ¿ ³»½Ã°æ Àç󸮱â(AER), ³ôÀº ¼öÁØÀÇ ¼Òµ¶Á¦, °ÇÁ¶/º¸°ü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ ¹®¼­È­ ¹× ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº ±â¼ú ¹ßÀüÀº È¿À²¼ºÀ» °³¼±ÇÏ°í ½Ç½Ã°£ ÄÄÇöóÀ̾𽺠ÃßÀûÀ» Áö¿øÇϱâ À§ÇØ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄɾî ÅõÀÚ Áõ°¡¿Í º´¿ø ³» ¹«±Õ ó¸® ºÎ¹®(CSPD)ÀÇ ÁýÁßÈ­ Ãß¼¼´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ³»½Ã°æ ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä, °¨¿° °ü¸® ±ÔÁ¦, ±â¼ú ¹ßÀü, ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ µîÀÇ ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ³»½Ã°æ Àçó¸® ½ÃÀåÀº °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, Çö´ë ÀÇ·áÀÇ °¨¿° °ü¸® ¹× ȯÀÚ ¾ÈÀüÀÇ ±Ù°£ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° ºÎ¹®(°í¼öÁØ ¼Òµ¶¾à ¹× Å×½ºÆ® ½ºÆ®¸³, ¼¼Á¤Á¦ ¹× ¹°Æ¼½´, ³»½Ã°æ ÀÚµ¿ Àçó¸® Àåºñ(AERs), ³»½Ã°æ °ÇÁ¶¡¤º¸°ü¡¤ÀÌ¼Û ½Ã½ºÅÛ, ³»½Ã°æ ÃßÀû ½Ã½ºÅÛ, ±âŸ Á¦Ç° ºÎ¹®), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°è °íÀ¯ÀÇ SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Endoscope Reprocessing Market to Reach US$5.0 Billion by 2030

The global market for Endoscope Reprocessing estimated at US$3.2 Billion in the year 2024, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. High-Level Disinfectants & Test Strips, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Detergents & Wipes segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$826.9 Million While China is Forecast to Grow at 11.7% CAGR

The Endoscope Reprocessing market in the U.S. is estimated at US$826.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Endoscope Reprocessing Market - Key Trends & Drivers Summarized

Why Is Endoscope Reprocessing Essential in Healthcare?

Endoscope reprocessing is a critical procedure in healthcare settings, designed to ensure that endoscopic instruments used in diagnostics and surgeries are thoroughly cleaned, disinfected, or sterilized between patients. Proper reprocessing is essential to prevent cross-contamination and infection transmission, particularly with endoscopes, which are reusable and often come into contact with mucous membranes and sterile tissues. The reprocessing of endoscopes involves multiple steps, including pre-cleaning, high-level disinfection, rinsing, drying, and storage, and it is strictly regulated by health authorities to minimize infection risks.

The demand for endoscope reprocessing is especially high in areas like gastroenterology, urology, and pulmonology, where endoscopes are frequently used for minimally invasive procedures. Given the rise in healthcare-acquired infections (HAIs), healthcare facilities are increasingly focusing on strict reprocessing protocols to ensure patient safety and meet regulatory compliance. Endoscope reprocessing solutions, including automated reprocessing units, high-level disinfectants, and drying/storage systems, are indispensable in hospitals, clinics, and outpatient centers, supporting high standards of hygiene and patient care in healthcare facilities worldwide.

How Are Technological Advancements Shaping the Endoscope Reprocessing Market?

Technological advancements are transforming endoscope reprocessing by improving efficiency, automation, and compliance with safety standards. Automated endoscope reprocessors (AERs) are one of the most significant advancements, providing a reliable, consistent, and standardized process for cleaning and disinfecting endoscopes. AERs help to streamline reprocessing workflows, reduce manual handling, and minimize the risk of human error, ensuring that each endoscope is processed according to strict guidelines. Additionally, AERs often include digital tracking and documentation features, allowing healthcare providers to maintain accurate records for quality control and regulatory compliance.

Enhanced disinfectants and sterilants are also being developed, offering quicker and more effective pathogen elimination, with formulations that are safer for both healthcare workers and the environment. New high-level disinfectants with shorter cycle times and broad-spectrum antimicrobial effectiveness improve turnaround time for endoscopes, supporting faster patient care. Moreover, advancements in drying and storage solutions, such as automated drying cabinets and filtered air systems, help ensure that endoscopes are properly dried and stored in a contaminant-free environment, further reducing infection risks. These technological innovations are making endoscope reprocessing faster, safer, and more compliant with stringent healthcare standards.

What Are the Key Applications of Endoscope Reprocessing?

Endoscope reprocessing is crucial across various healthcare settings where endoscopic procedures are performed, including gastroenterology, pulmonology, urology, and general surgery. In gastroenterology, reprocessing ensures that flexible endoscopes used in colonoscopies, gastroscopies, and ERCP (Endoscopic Retrograde Cholangiopancreatography) are safe for reuse, as these procedures require sterile instruments due to contact with internal tissues. Similarly, in pulmonology, bronchoscopes used in airway inspections and lung biopsies are reprocessed to prevent respiratory infections among patients.

In urology, cystoscopes used in the diagnosis and treatment of urinary tract conditions undergo strict reprocessing to prevent the transmission of urinary tract infections. Additionally, in surgical departments, rigid endoscopes like laparoscopes and arthroscopes are reprocessed to maintain sterile conditions during minimally invasive surgeries. These reprocessing procedures ensure that all endoscopic instruments are contamination-free, supporting patient safety and maintaining high standards of infection control across healthcare facilities. Each application underscores the importance of rigorous reprocessing protocols to minimize the risk of infections and ensure safe, effective patient care.

What Is Driving Growth in the Endoscope Reprocessing Market?

The growth in the endoscope reprocessing market is driven by increasing demand for endoscopic procedures, rising awareness of infection prevention, regulatory pressures for high-level disinfection, and advancements in reprocessing technology. As minimally invasive endoscopic procedures become more common for diagnostic and therapeutic applications, the need for effective reprocessing solutions grows, particularly to keep pace with high patient throughput. Rising awareness of healthcare-acquired infections (HAIs) and their impact on patient safety and healthcare costs is driving healthcare facilities to adopt advanced reprocessing systems that offer reliable disinfection and traceability.

Regulatory bodies, such as the FDA, CDC, and various health ministries worldwide, enforce strict reprocessing standards for endoscopes, mandating specific protocols and documentation to ensure compliance and accountability. This regulatory focus on infection prevention is propelling demand for automated endoscope reprocessors (AERs), high-level disinfectants, and drying/storage systems that meet regulatory requirements and reduce the likelihood of HAIs. Technological advancements, including automated documentation and monitoring systems, are further encouraging the adoption of these solutions, as they improve efficiency and support real-time compliance tracking.

Moreover, increasing healthcare investments, especially in emerging markets, and the trend towards centralized sterile processing departments (CSPDs) in hospitals are contributing to market growth. Together, these factors-demand for endoscopic procedures, infection control regulations, technological advancements, and investments in healthcare infrastructure-are driving strong growth in the endoscope reprocessing market, making it a fundamental aspect of infection control and patient safety in modern healthcare.

SCOPE OF STUDY:

The report analyzes the Endoscope Reprocessing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Segment (High-Level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AERs), Endoscope Drying, Storage & Transport Systems, Endoscope Tracking Systems, Other Product Segments); End-Use (Hospitals, Ambulatory Surgery Centers, Other End Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â